Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alice P. Chen, MD
National Cancer Institute (NCI)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Melbourne, Australia
- Research Site
St Leonards, Australia
- Research Site
Porto Alegre, Brazil
- Research Site
Ribeirão Preto, Brazil
- Research Site
São Paulo, Brazil
- Research Site
Toronto, Ontario, Canada
- Research Site
Montreal, Quebec, Canada
- Research Site
Beijing, China
- Research Site
Beijing, China
- Research Site
Guangzhou, China
- Research Site
Shenyang, China
- Research Site
Créteil, France
- Research Site
Lyon, France
- Research Site
Toulouse, France
- Research Site
Hamburg, Germany
- Research Site
Tübingen, Germany
- Research Site
Würzburg, Germany
- Research Site
Milan, Italy
- Research Site
Naples, Italy
- Research Site
Roma, Italy
- Research Site
Minatoku, Japan
- Research Site
Nagoya, Japan
- Research Site
Shinjuku-ku, Japan
- Research Site
Bydgoszcz, Poland
- Research Site
Moscow, Russia
- Research Site
Moscow, Russia
- Research Site
Badalona, Spain
- Research Site
Madrid, Spain
- Research Site
London, United Kingdom
- Research Site
Manchester, United Kingdom
- Research Site
Gainesville, Florida, United States
- Research Site
Rockville, Maryland, United States
- Research Site
St Louis, Missouri, United States
- Research Site
Commack, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Nov 2021
- Primary completion
- 5 Aug 2024
- Completion
- 15 Feb 2029
- Last update posted
- 23 Mar 2026
- Registered enrollment
- 145
- Registry id
- NCT04924608
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.